• Cost-Effectiveness and Value of Information Analysis of Brief Interventions to Promote Physical Activity in Primary Care

    Jan 1, 2018, 00:00

  • Conducting a Discrete-Choice Experiment Study Following Recommendations for Good Research Practices- An Application for Eliciting Patient Preferences for Diabetes Treatments

    Jan 1, 2018, 00:00

  • Editorial Board

    Jan 1, 2018, 00:00

  • Comparison of Adalimumab and Etanercept for the Treatment of Moderate to Severe Psoriasis- An Indirect Comparison Using Individual Patient Data from Randomized Trials

    Jan 1, 2018, 00:00

  • Instructions for Authors

    Jan 1, 2018, 00:00

  • Using a Discrete-Choice Experiment Involving Cost to Value a Classification System Measuring the Quality-of-Life Impact of Self-Management for Diabetes

    Jan 1, 2018, 00:00

  • Women’s Benefits and Harms Trade-Offs in Breast Cancer Screening- Results from a Discrete-Choice Experiment

    Jan 1, 2018, 00:00

  • Standards for Instrument Migration When Implementing Paper Patient-Reported Outcome Instruments Electronically- Recommendations from a Qualitative Synthesis of Cognitive Interview and Usability Studies

    Jan 1, 2018, 00:00

  • Identifying Psoriasis and Psoriatic Arthritis Patients in Retrospective Databases When Diagnosis Codes Are Not Available- A Validation Study Comparing Medication/Prescriber Visit–Based Algorithms with Diagnosis Codes

    Jan 1, 2018, 00:00

  • An Economic Evaluation of the Impact, Cost, and Medicare Policy Implications of Chronic Nonhealing Wounds

    Jan 1, 2018, 00:00

  • The Burden of Peristomal Skin Complications on an Ostomy Population as Assessed by Health Utility and the Physical Component Summary of the SF-36v2

    Jan 1, 2018, 00:00

  • EQ-5D- Moving from Three Levels to Five

    Jan 1, 2018, 00:00

  • EQ-5D-5L versus EQ-5D-3L- The Impact on Cost Effectiveness in the United Kingdom

    Jan 1, 2018, 00:00

  • Trading Bankruptcy for Health- A Discrete-Choice Experiment

    Jan 1, 2018, 00:00

  • Effects of Transitioning to Medicare Part D on Access to Drugs for Medical Conditions among Dual Enrollees with Cancer

    Dec 1, 2017, 00:00

  • Comparison of Timed Automata with Discrete Event Simulation for Modeling of Biomarker-Based Treatment Decisions- An Illustration for Metastatic Castration-Resistant Prostate Cancer

    Dec 1, 2017, 00:00

  • Patient Preferences for Device-Aided Treatments Indicated for Advanced Parkinson Disease

    Dec 1, 2017, 00:00

  • An Exploratory Study on Using Principal-Component Analysis and Confirmatory Factor Analysis to Identify Bolt-On Dimensions- The EQ-5D Case Study

    Dec 1, 2017, 00:00

  • Cost Effectiveness of the Angiotensin Receptor Neprilysin Inhibitor Sacubitril/Valsartan for Patients with Chronic Heart Failure and Reduced Ejection Fraction in the Netherlands- A Country Adaptation Analysis Under the Former and Current Du ...

    Dec 1, 2017, 00:00

  • Cost Effectiveness of Candida Polymerase Chain Reaction Detection and Empirical Antifungal Treatment among Patients with Suspected Fungal Peritonitis in the Intensive Care Unit

    Dec 1, 2017, 00:00

  • Effect of Dipeptidyl Peptidase-4 Inhibitors on Heart Failure- A Network Meta-Analysis

    Dec 1, 2017, 00:00

  • Table of Contents

    Dec 1, 2017, 00:00

  • Letter to the Editor- Emerging Guidelines for Patient Engagement in Research

    Dec 1, 2017, 00:00

  • Scientific Evidence in Health Technology Assessment Reports- An In-Depth Analysis of European Assessments on High-Risk Medical Devices

    Dec 1, 2017, 00:00

  • Value of Implementation of Strategies to Increase the Adherence of Health Professionals and Cancer Survivors to Guideline-Based Physical Exercise

    Dec 1, 2017, 00:00

  • Copyright/Subscription

    Dec 1, 2017, 00:00

  • Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer- The OPTIMA Prelim Trial

    Dec 1, 2017, 00:00

  • A (Latent) Class of Their Own- Response Patterns in Trading Off Quantity and Quality of Life in Time Trade-Off Exercises

    Dec 1, 2017, 00:00

  • ISPOR Code of Ethics 2017 (4th Edition)

    Dec 1, 2017, 00:00

  • Basal Insulin Regimens for Adults with Type 1 Diabetes Mellitus- A Cost-Utility Analysis

    Dec 1, 2017, 00:00

  • Editorial Board

    Dec 1, 2017, 00:00

  • Comparing Methods for Estimating Direct Costs of Adverse Drug Events

    Dec 1, 2017, 00:00

  • Nephrectomy Complication Is a Risk Factor of Clinically Meaningful Decrease in Health Utility among Living Kidney Donors

    Dec 1, 2017, 00:00

  • Author Response- Patient Engagement

    Dec 1, 2017, 00:00

  • Incremental Costs and Cost Effectiveness of Intensive Treatment in Individuals with Type 2 Diabetes Detected by Screening in the ADDITION-UK Trial- An Update with Empirical Trial–Based Cost Data

    Dec 1, 2017, 00:00

  • The Use of Decomposition Methods in Real-World Treatment Benefits Evaluation for Patients with Type 2 Diabetes Initiating Different Injectable Therapies- Findings from the INITIATOR Study

    Dec 1, 2017, 00:00

  • Comparison of Oral Anticoagulants for Stroke Prevention in Nonvalvular Atrial Fibrillation- A Multicriteria Decision Analysis

    Dec 1, 2017, 00:00

  • Forecasting the Long-Term Clinical and Economic Outcomes of Lumacaftor/Ivacaftor in Cystic Fibrosis Patients with Homozygous phe508del Mutation

    Dec 1, 2017, 00:00

  • Next Edition of the ISPOR Code of Ethics- Is It Setting Us up for the Era of Digitized Health Care?

    Dec 1, 2017, 00:00

  • Development and Validation of the AFImpact- An Atrial Fibrillation–Specific Measure of Patient-Reported Health-Related Quality of Life

    Dec 1, 2017, 00:00

  • Reviewer Acknowledgement 20/10

    Dec 1, 2017, 00:00

  • Health Care System

    Dec 1, 2017, 00:00

  • The Role of Noncomparative Evidence in Health Technology Assessment Decisions

    Dec 1, 2017, 00:00

  • Value and Impact of Incorporating Uncertainty into Opinion Based Research- Study on American College of Medical Genetics (ACMG) Recommendations for Newborn Screening (NBS) for Cystic Fibrosis (CF)

    Oct 1, 2017, 00:00

  • Estimating The Drug Treatment Cost of Breast Cancer

    Oct 1, 2017, 00:00

  • Costs and Benefits of Implementing Non-Invasive Prenatal Testing For Trisomy 21 (T21) Based on Cell Free DNA (CFDNA) Sequencing In Maternal Plasma In France

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Afatinib Versus Gefitinib in Egfr-Mutated Population with Advanced Non-Small-Cell Lung Cancer in France

    Oct 1, 2017, 00:00

  • Patient Insights In Copd Medication Adherence From Pharmacy Data

    Oct 1, 2017, 00:00

  • Time To Market Access For Oncology Medicines In Gree Has It Changed During The Crisis?

    Oct 1, 2017, 00:00

  • Effects of Adherence to Pharmacological Secondary Prevention After Myocardial Infarction on Healthcare Expenditures

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Edoxaban In Patients With Non-Valvular Atrial Fibrillation In Hong Kong

    Oct 1, 2017, 00:00

  • Adherence Patterns Among Patients Using Oral Atypical Antipsychotics and Other Medications

    Oct 1, 2017, 00:00

  • Longitudinal Study into the Dispensing Patterns of Benzodiazepines and Z-Drugs in a South African Private Healthcare Setting

    Oct 1, 2017, 00:00

  • Real Life Cost of Treatment and Follow-Up in Glioblastoma Multiforme (GBM) Patients Treated at the Antwerp University Hospital (UZA), Belgium

    Oct 1, 2017, 00:00

  • The Impact Of Human Papillomavirus Vaccine In Taiwan- A Transmission Dynamic Modelling Approach

    Oct 1, 2017, 00:00

  • The Utilisation Of Biosimilar Infliximab By English Acute Trusts

    Oct 1, 2017, 00:00

  • Social And Financial Impact Of Dravet Syndrome

    Oct 1, 2017, 00:00

  • Conceptual Modeling Framework for Global Functioning of Adhd Patients

    Oct 1, 2017, 00:00

  • Cluster-Randomized, Crossover Trial of Head Positioning in Acute Stroke

    Oct 1, 2017, 00:00

  • Modelling Patient Pathways Of Low-Dose Computed Tomography Screening For Lung Cancer In Hungary

    Oct 1, 2017, 00:00

  • Maximum Difference Scaling To Enhance Insight In Qualitative Payer Research

    Oct 1, 2017, 00:00

  • Real World Evidence in Glaucomatous Diseases- Emr Data is Indispensible For Understanding Patient Journeys and Optimizing Care

    Oct 1, 2017, 00:00

  • Intensity Modulated Radiation Therapy In Malignant Pleural Mesothelioma; A Piolt For Treatment Outcomes And Cost-Effective Expectations

    Oct 1, 2017, 00:00

  • Impact Of Non-Randomised Drop-Out On Treatment Switching Adjustment In The Relapsing-Remitting Multiple Sclerosis Clarity Trial And The Clarity Extension Study

    Oct 1, 2017, 00:00

  • Retrospective Analysis of Patients Treated with Computer-Assisted External Ring Fixators- A Descriptive Analysis of Patient Demographics, Healthcare Untilization, And Costs In The U.S

    Oct 1, 2017, 00:00

  • Economic Evaluation Of A Brief Counselling For Smoking Cessation In Dentistry – A Case Study Comparing Two Health Economic Models

    Oct 1, 2017, 00:00

  • Market Access of Nintedanib for Idiopathic Pulmonary Fibrosis- A Cross-Country Review of Access Conditions

    Oct 1, 2017, 00:00

  • Real-World Data Analysis of Cancer Treatment Cost Drivers By Type and Place of Service

    Oct 1, 2017, 00:00

  • Pharmacoepidemiological Survey Of Under- Five Antidiarrhea Drugs Utilization In A Tertiary Teaching Hospital In Enugu Metropolis Southeast Nigeria

    Oct 1, 2017, 00:00

  • Evolution of The Time-To-Market of Hospital Products In Spain

    Oct 1, 2017, 00:00

  • Dispute Issues About The Healing And Health Promotion Of Children

    Oct 1, 2017, 00:00

  • Análisis Comparativo De Costos Entre Trastuzumab Para Administración Subcutánea En Comparación Con La Formulación Para Administración Intravenosa Desde La Perspectiva De La Seguridad Social Costarricense

    Oct 1, 2017, 00:00

  • Decision Analytic Modelling Methods For The Assessing The Effectiveness Of Treatment Sequences For Clinical And Economic Decision Making- A Methodological Review

    Oct 1, 2017, 00:00

  • Intermediate Evaluation of Vivoptim- The Mgen (French Insurer) Prevention Program for Cardiovascular Risks

    Oct 1, 2017, 00:00

  • Economic Burden of Autism and Autism-Related Spectrum Disorders (Asd) In EU5 Countries

    Oct 1, 2017, 00:00

  • Cost and Effectiveness of the use of Sorafenib in Differentiated Thyroid Cancer

    Oct 1, 2017, 00:00

  • Factors Associated with Medication Adherence in Korean Postmenopausal Osteoporosis(PMO)- Results from PMO Outcomes Research(OR)

    Oct 1, 2017, 00:00

  • Determining The Value of Selexipag For The Treatment of Pulmonary Arterial Hypertension (PAH) In Spain By Multi-Criteria Decision Analysis (MCDA)

    Oct 1, 2017, 00:00

  • Processes And Requirements For Health Economic Assessment Of Antibiotics For Hta Purposes- Time For A Paradigm Shift?

    Oct 1, 2017, 00:00

  • Characterization And Approximation Of The Direct Costs Of Axial And Peripheral Spondyloarthritis In A Clinical Management Center In Colombia

    Oct 1, 2017, 00:00

  • Comparison of the Assessments and Recommendations Issued by Brazil’s Conitec and Canada’s Cadth for Select Oncology Drugs

    Oct 1, 2017, 00:00

  • Systematic Review On Economic Impact Of Air Pollution On Health

    Oct 1, 2017, 00:00

  • Real-World Health Care Expenditure In Hemophilia B Patients Using Standard And Extended Half-Life Recombinant Factor IX Products

    Oct 1, 2017, 00:00

  • Impact of Metabolic Surgery on Cost and Long-Term Health Outcome- A Cost-Effectiveness Approach

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Secukinumab in Ankylosing Spondylitis- A Canadian Perspective

    Oct 1, 2017, 00:00

  • A Cost-Effectiveness Modeling Evaluation Comparing Originator Follitropin Alfa To A Biosimilar For The Treatment of Infertility In Germany, Italy And Spain

    Oct 1, 2017, 00:00

  • Descalonamento Da Terapia Antimicrobiana- Uma Estratégia De Racionalização E Custo-Minimização Em Cenário Privado De Saúde No Ceará

    Oct 1, 2017, 00:00

  • Burden Of Illness Of Pulmonary Embolism In Europe – Mortality And Health Related Quality Of Life

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Thresholds- Review Of Cases Around The World

    Oct 1, 2017, 00:00

  • When And Where To Use Furigana? The Application Of Phonetic Notation In Japanese Translations Of Clinical Outcomes Assessments (COAS) For Children

    Oct 1, 2017, 00:00

  • Advanced Monte-Carlo Sampling Schemes for Value of Information Estimation

    Oct 1, 2017, 00:00

  • Secondary Care Resource Utilization And Cost Of Care Among Finnish Inflammatory Bowel Disease Patients

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Statin Prioritisation Based on Absolute Risk Reduction For Primary Prevention of Cardiovascular Disease

    Oct 1, 2017, 00:00

  • DATABASE ANALYSIS OF A SUPPORT PROGRAM FOR PEDIATRIC PATIENTS USING SOMATROPIN DUE TO GROWTH HORMONE DEFICIENCY (GHD)

    Oct 1, 2017, 00:00

  • Capturing Patient Perspectives In The Evaluation Of Medical Devices- The Case Of Central Venous Access Devices In Chemotherapy

    Oct 1, 2017, 00:00

  • Xelox Versus Folfox No Tratamento Do Câncer Colorretal- Revisão De Estudos Farmacoeconômicos

    Oct 1, 2017, 00:00

  • Economic Impact Of Floseal In Cardiac Surgery From The Perspective Of The Mexican Institute Of Social Security (IMSS)

    Oct 1, 2017, 00:00

  • Direct Oral Anticoagulants Versus Low-Molecular-Weight Heparins for Venous Thromboembolism Prevention Following Total HIP Replacement- Comparative Effectiveness and Medical Costs from a French Nationwide Cohort Study of Around 120,000 Patie ...

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Nivolumab in Combination with Ipilimumab in First-Line Treatment of Advanced Melanoma in Sweden- Analysis Using 28-Month Overall Survival from Checkmate 067

    Oct 1, 2017, 00:00

  • Impact Of Seasonal Infections On Overcrowding In A Paediatric Department Of A French Hospital In Marseille- A Retrospective Analysis

    Oct 1, 2017, 00:00

  • Pricing Pressures And Market Access Outcomes Of Advanced Therapy Medicinal Products (Atmps) In The Eu5

    Oct 1, 2017, 00:00

  • Second-Line Therapy In Patients with Locally Advanced or Metastatic Urothelial Cancer- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Efficacy-Based Budget Impact Analysis of Secukinumab Vs Adalimumab in the Treatment of Ankylosing Spondylitis in Finland

    Oct 1, 2017, 00:00

  • Payers, Politics and Pandemonium- An Insight Into The Future Uk Pricing and Market Access Environment

    Oct 1, 2017, 00:00

  • The Association Between Buprenorphine/Naloxone and All-Cause Mortality in the United Kingdom (UK)- An Interim Report

    Oct 1, 2017, 00:00

  • A Cost-Utility Analysis Of Raasi Enabling-Patiromer In Patients With Hyperkalemia

    Oct 1, 2017, 00:00

  • Economic Evaluation And Budget Impact Analysis Of Prothrombin Complex Concentrate (Beriplex®) For Treatment And Prophylaxis Of Bleeding In Patients Treated With Oral Anticoagulants Under Perspective Of Health Public Institutions In Mexico

    Oct 1, 2017, 00:00

  • Publication Timing and Data Utilisation in Cost-Effectiveness Analyses in Non-Small Cell Lung Cancer – A Literature Analysis on Publication Timing

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Apixaban In Prevention of Stroke And Systemic Embolism In The Czech Republic

    Oct 1, 2017, 00:00

  • From Evaluation To Optimization- Using A Meta-Model To Maximize The Benefits Of Colorectal Screening Accounting For Capacity Constraints

    Oct 1, 2017, 00:00

  • An Innovative Solution to Achieve Cost-effectiveness and A Positive Nice Appraisal? – The Cabazitaxel Case Study

    Oct 1, 2017, 00:00

  • Community Pharmacists’ Interest In And Attitude To Pharmacy Practice Research In Ethiopia- A Cross-Sectional Study

    Oct 1, 2017, 00:00

  • The Real-World Impact Of Mild To Moderate Hypoglycemic Events In Portugal – Results From The Hipos-Pharma Study

    Oct 1, 2017, 00:00

  • The Presentation Of Patients With Epistaxis Shows A Marked Seasonal Variation In Germany

    Oct 1, 2017, 00:00

  • Budget Impact Model of Cobimetinib in Combination with Vemurafenib For Previously Untreated Braf V600-Mutation Positive Patients With Unresectable Locally Advanced or Metastatic Melanoma

    Oct 1, 2017, 00:00

  • A Retrospective Study On The Antiretroviral Drug Dispensing And Adherence Of The Hungarian HIV Infected Population

    Oct 1, 2017, 00:00

  • Health-Related Quality of Life after Major Lower Extremity Amputation Due to Musculoskeletal Tumors

    Oct 1, 2017, 00:00

  • Identification Of Important Criteria For Drug Reimbursement Decision-Making And Their Relative Importance

    Oct 1, 2017, 00:00

  • Evaluating The Importance Of Realistically Simulating Risk Factor Progression Over Time- A Health Economic Modeling Analysis In Type 1 Diabetes

    Oct 1, 2017, 00:00

  • Cost Effectiveness Of Urban Breast Cancer Screening Programme In China

    Oct 1, 2017, 00:00

  • Safety of A Specific First Line Antiretroviral Regimen- A Review

    Oct 1, 2017, 00:00

  • Evaluating Endpoints and Changing Trends In Advanced Stages of Cancer Related Clinical Trials

    Oct 1, 2017, 00:00

  • A Budget Impact Model of The Addition of Telotristat Ethyl Treatment In Patients With Uncontrolled Carcinoid Syndrome

    Oct 1, 2017, 00:00

  • AVALIAÇÃO ECONÔMICA DE TECNOLOGIAS NA ÁREA DE NUTRIÇÃO- APLICAÇÕES E LIMITAÇÕES PARA O CONTEXTO BRASILEIRO

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Breech Version By Moxibustion Associated With Acupuncture For Women At 33 Weeks Gestation- A Modeling Approach By The Brazilian Public Health Care System Perspective

    Oct 1, 2017, 00:00

  • The Analysis Of New Drug Reimbursement Decision Making In South Korea After The Introduction Of Positive Listing System

    Oct 1, 2017, 00:00

  • Effectiveness and Persistence of The First Tumor Necrosis Factor Inhibitor In Portuguese Psoriatic Arthritis Patients

    Oct 1, 2017, 00:00

  • Are PR Approval Of Orphan Drugs (ODS) In Spain?

    Oct 1, 2017, 00:00

  • A Longitudinal Investigation Of The Relationships Between Patient-Reported Symptoms And Survival Among Patients with HR+/HER2- Metastatic Breast Cancer (MBC) Treated With Abemaciclib In The Phase 2 Monarch 1 Trial

    Oct 1, 2017, 00:00

  • Remote Therapy Management Of Patients On Automated Peritoneal Dialysis Demonstrates Cost Savings In Germany And Italy

    Oct 1, 2017, 00:00

  • Time To Clinically Meaningful Worsening In Hepatocellular Carcinoma Patients Treated With Lenvatinib or Sorafenib

    Oct 1, 2017, 00:00

  • Economic Evaluation Of Dexmedetomidine Versus Propofol Or Midazolam Sedation In Mechanical Ventilated Icu Patients In Spain

    Oct 1, 2017, 00:00

  • Phase I/II Based Early Economic Evaluation of Acalabrutinib for Relapsed Chronic Lymphocytic Leukemia

    Oct 1, 2017, 00:00

  • 10 Years Of Reimbursement Decisions In The Netherlands- An Overview

    Oct 1, 2017, 00:00

  • The Cost Effectiveness of Sacubitril/Valsartan For The Treatment of Chronic Heart Failure With Reduced Ejection Fraction In Korea

    Oct 1, 2017, 00:00

  • Clinical Outcome Assessments For Patients With Hemophilia

    Oct 1, 2017, 00:00

  • Implementability Evaluation Of Antibiotics For Abdominal Trauma Guideline Using The Guideline Implementability Appraisal (GLIA) Tool

    Oct 1, 2017, 00:00

  • An Evidence-Based Approach to Predict Long-Term Patient Outcomes and Key Value Drivers

    Oct 1, 2017, 00:00

  • Early Scientific Advice At Cadth – Options and Recommendations For Future Development

    Oct 1, 2017, 00:00

  • Examining Global Occurrence Of Complications Related To Peripheral Iv Catheters Using A Focused Literature Review

    Oct 1, 2017, 00:00

  • Secukinumab vs. Adalimumab for the Treatment of Psoriatic Arthritis- A Cost Per Responder Analysis at 48 Weeks from a Brazilian Perspective

    Oct 1, 2017, 00:00

  • Budget Impact Analysis Of Biosimilar Rituximab (CT-P10) For The Treatment Of Diffuse Large B-Cell And Follicular Lymphoma In The 28 EU Member States

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Apremilast for The Treatment of Moderate To Severe Psoriasis In Greece

    Oct 1, 2017, 00:00

  • Healthcare Costs of Ipilimumab in Patients with Advanced Cutaneous Melanoma in Dutch Clinical Practice

    Oct 1, 2017, 00:00

  • Gene-Therapy, The Way Forward In Europe – The Payer Perspective

    Oct 1, 2017, 00:00

  • Association Between Monthly Joint Replacement Volume and Patient Outcomes

    Oct 1, 2017, 00:00

  • Defining Criteria Weights By AHP In Health Technology Assessment

    Oct 1, 2017, 00:00

  • Visual Outcome of Cataract Surgery At Gondar University Hospital Tertiary Eye Care and Training Center, North West Ethiopia

    Oct 1, 2017, 00:00

  • Economic Burden of Gastric Cancer in Turkey

    Oct 1, 2017, 00:00

  • Hospital Costs Associated With Dedicated Vascular Endoprosthesis Versus Prosthetic Bypass In Popliteal Artery Aneurysm Treatment In France

    Oct 1, 2017, 00:00

  • Quality of Life And Utility Decrement Associated With Clostridium Difficile Infection In French Acute Care Facilities

    Oct 1, 2017, 00:00

  • Disease-Modifying Therapy Is Associated With Lower Medical Costs In Patients With Multiple Sclerosis With or Without Corticosteroid Treatment- A Us Retrospective Claims-Based Study

    Oct 1, 2017, 00:00

  • Analytical Hierarchical Process for Evaluation of First Line Treatment of Metastatic HER2 Overexpressed Breast Cancer from Brazilian Health System Perspective

    Oct 1, 2017, 00:00

  • IQWIG´S GENERAL METHODS 5.0 - WHAT´S NEW?

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Sacubitril/Valsartan Introduction For Heart Failure Treatment From The French Hospital Perspective

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of A Multi-Gene Panel In The Context Of Reducing Adverse Drug Reactions

    Oct 1, 2017, 00:00

  • Physiotherapeautic Methods Aimed To Improve The Cardiorespiratory State Before And After Operation In Patients With Lung Cancer

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Sacubitril/Valsartan Compared With Standard Acei Therapies For Heart Failure Patients With Reduced Ejection Fraction In Taiwan

    Oct 1, 2017, 00:00

  • Epidemiology of Multiple Sclerosis- Literature Review for Prevalence and Trend Over Time in 5 European Countries and Canada

    Oct 1, 2017, 00:00

  • Treatment Patterns for Adult Patients with Newly Diagnosed Focal Epilepsy in Germany

    Oct 1, 2017, 00:00

  • Microbiological, Chemical Analysis and Comparison of Public Bath Waters in Baranya County Between 2010-2016

    Oct 1, 2017, 00:00

  • Cost Associated with Ballon-Expandable Valve vs Self-Expandable Valves in Patients Undergoing Transcatheter Aortic Valve Replacement

    Oct 1, 2017, 00:00

  • Creating Order In Chaos - The Impact Of Brexit On The Regulatory Environment In Europe And The United Kingdom

    Oct 1, 2017, 00:00

  • Preliminary Results of Restarting Oral Anticoagulant Treatment In Patients with Non-Valvular Atrial Fibrillation Following Intracranial Hemorrhage- A Population-Based Cohort Study

    Oct 1, 2017, 00:00

  • Relation of QLQ-C30 and QLQ-CR29 Health Related Quality of Life Scales and Biochemical Indicators of Nutritional Status

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Treatment with Ultibro Breezhaler® Versus Seretide Diskus® 50/500 Μg for Moderate to Very Severe COPD Patients

    Oct 1, 2017, 00:00

  • A Discrete Event Simulation Model For Renal Cell Carcinoma For Use In A Cost-Effectiveness Analysis

    Oct 1, 2017, 00:00

  • Review Of Models Submitted To Nice Medical Technologies Evaluation Programme To Inform A Cost Consequence Template For Use In Medical Technologies Guidance Submissions

    Oct 1, 2017, 00:00

  • Análisis Del Costo De La Atención Del Parto En Medellín

    Oct 1, 2017, 00:00

  • Navigating The Road To Reimbursement And Optimizing Uptake For Oncology Agents In The EU5- Payer And Prescriber Perspectives On The Power Of Pivotal Trial Design

    Oct 1, 2017, 00:00

  • Statistical Methods for Critical Care Outcomes

    Oct 1, 2017, 00:00

  • Willingness-To-Pay For Life-Saving Treatments In Thailand- A Discrete Choice Experiment

    Oct 1, 2017, 00:00

  • Patient Care Pathway for Post-Stroke Spasticity and Bont Management in French Hospitals Through the Prism of PMSI Data

    Oct 1, 2017, 00:00

  • Burden Of Diabetes Mellitus In Patients With Acromegaly Treated With Second-Line Pharmacotherapy In Spain

    Oct 1, 2017, 00:00

  • GROWTH FACTORS FOR THE MANAGEMENT OF DIABETIC FOOT ULCERS- MIXED TREATMENT COMPARISONS OF RANDOMIZED CONTROLLED TRIALS

    Oct 1, 2017, 00:00

  • Impacto Económico Directo Derivado De La Atención De Pacientes Traumatizados En UN Hospital De México

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Nivolumab in Combination with Ipilimumab in First-Line Treatment of Advanced Melanoma in Three European Countries Using 28-Month Overall Survival from Checkmate 067

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Fidaxomicin Versus Vancomycin And Metronidazole In Patients With Clostridium Difficile Infection In Spain

    Oct 1, 2017, 00:00

  • Comparing the Efficacy, Safety, and Efficiency Outcomes Between Lensx Femtosecond Laser-Assisted Cataract Surgery and Phacoemulsification Cataract Surgery- A Meta-Analysis

    Oct 1, 2017, 00:00

  • Cost Savings of Perioperative Anemia Treatment with Ferric Carboxymaltose In Colorectal Cancer Surgery Patients

    Oct 1, 2017, 00:00

  • Análise De Impacto Orçamentário Do Crizotinibe No Tratamento Do Câncer De Pulmão Não Pequenas Células Avançado Alk-Positivo Sob a Perspectiva Do Sistema Privado De Saúde Brasileiro

    Oct 1, 2017, 00:00

  • Diferencias Geográficas En La Salud Auto-Percibida Comunal De Chile

    Oct 1, 2017, 00:00

  • Opioid Utilization And Cost Among Elderly And Non-Elderly Medicare Beneficiaries In The United States- A State-Level Comparison

    Oct 1, 2017, 00:00

  • Secukinumab As A More Efficient Alternative For The Treatment of Ankylosing Spondylitis- A Cost Per Responder Analysis Versus Adalimumab And Golimumab From A Colombian Perspective

    Oct 1, 2017, 00:00

  • Do we Know Enough Yet? A Cumulative Cost-Effectiveness Analysis of Mechanical Thrombectomy

    Oct 1, 2017, 00:00

  • Gasto Y Cobertura De Inmunización En Niños Menores De Un Año De Edad En Ecuador

    Oct 1, 2017, 00:00

  • Prevalence And Perception Of Antibiotics Use In Balochistan

    Oct 1, 2017, 00:00

  • Type of Ancestral Native Plants Used as Intestinal Antiparasitic in Indigenous Communities- The Evanes Project

    Oct 1, 2017, 00:00

  • Societal Costs of Er+/Her2- Advanced or Metastatic Breast Cancer in Post-Menopausal Women in The United Kingdom

    Oct 1, 2017, 00:00

  • Detección Temprana Del Cáncer De Pulmón

    Oct 1, 2017, 00:00

  • Budget Impact of Atezolizumab for The Treatment of 2nd Line Non-Small Cell Lung Cancer (NSCLC) After Failure with Platinum Containing Chemotherapy in Greece

    Oct 1, 2017, 00:00

  • Prescription Writing Errors Detection by Pharmacist in A Pediatric Ward

    Oct 1, 2017, 00:00

  • Testosterone Replacement therapy As An Anti-Ageing Treatment for Men- A Literature Review and Economic Evaluation

    Oct 1, 2017, 00:00

  • Explaining Waiting Times for Scheduled Surgery Using A High-Dimensional Fixed Effects Model

    Oct 1, 2017, 00:00

  • Analysis Of Hospital Episode Statistics To Identify Hopsital Resource Use Due To Skin Cancer In Ireland

    Oct 1, 2017, 00:00

  • Survival Effect, Demand Effect And Policy Effect As Drivers For Pricing Of Innovatives Anticancer Drugs

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Continuous Versus Intermittent Renal Replacement Therapy for Critically ILL Acute Kidney Injury Patients Under the Perspective of the Brazilian Private Healthcare System

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Dolutegravir In HIV-1 Treatment-Naive Patients In Russia

    Oct 1, 2017, 00:00

  • Patients’ Priorities for Oral Anticoagulation Therapy in Non-Valvular Atrial Fibrillation

    Oct 1, 2017, 00:00

  • Systematic Review Of Economic Evaluation Studies For Dengue Vaccine- How Valid Are The Results?

    Oct 1, 2017, 00:00

  • Analysis of the G-BA Decision-Making Criteria on the Benefit Assessment of Diabetes Treatments- Is Cost an Influencing Criterion?

    Oct 1, 2017, 00:00

  • The Future of Precision Medicine- What Does it Mean for Nice?

    Oct 1, 2017, 00:00

  • Fluoroquinolone-Related Adverse Events Resulting In Health Care Use And Costs- A Systematic Review

    Oct 1, 2017, 00:00

  • Reimbursed Drugs with Alternative Payment Model in Turkey

    Oct 1, 2017, 00:00

  • The Role of Patient-Reported Outcomes and Patient Engagement In Health Technology Assessments and Reimbursement Decision Making In 10 Countries

    Oct 1, 2017, 00:00

  • Cost of Treatment for Chronic Hepatitis C Infection at a National Tertiary-Care Referral Centre in an Asian Middle-Income Country

    Oct 1, 2017, 00:00

  • Probabilistic Sensitivity Analysis In Health Economic Models; How Many Simulations Should We Run?

    Oct 1, 2017, 00:00

  • Trends In Emerging Non-Hta Drug Value Assessment Frameworks

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Assessment Of Herpes Zoster Vaccination In Germany

    Oct 1, 2017, 00:00

  • Market Access and Its Impact on Decision Making In Spain. An Example In Acute Myeloid Leukemia

    Oct 1, 2017, 00:00

  • Maximizing The Value of Wearable By The Remote Collection And Analysis Of Raw 100hz Data

    Oct 1, 2017, 00:00

  • The Situation and Importance of Peritoneal Dialysis In Renal Failure- Economic Analysis

    Oct 1, 2017, 00:00

  • A Retrospective Claims Analysis on Rates of Compliance and Discontinuation Among Canadian Multiple Sclerosis Patients Treated with Disease-Modifying Therapies at 6, 12 and 24-Month Periods

    Oct 1, 2017, 00:00

  • Effect of Pharmacist Care on Medication Adherence and Cardiovascular Outcomes Among Patients Post-Acute Coronary Syndrome- A Systematic Review

    Oct 1, 2017, 00:00

  • Epidemiology of Physician-Diagnosed Neuropathic Pain in Brazil

    Oct 1, 2017, 00:00

  • Maintaining The Belt And Road – The Impact of 'Brexit' on UK Market Access

    Oct 1, 2017, 00:00

  • Examination of The Effectiveness of Core Training Between Junior Women Basketball Players To Prevent Sports Injuries

    Oct 1, 2017, 00:00

  • Assessing The Burden Of Chronic Heart Failure (Chf) On Patients In Brazil

    Oct 1, 2017, 00:00

  • Dispensing Patterns of Anti-Migraine Agents with the Focus On Seasonal Variations In Prescribing

    Oct 1, 2017, 00:00

  • A Model-Based Meta-Analysis For The Effect of Metformin On Hba1c Levels In Patients With Type-2 Diabetes Mellitus

    Oct 1, 2017, 00:00

  • HTA Analysis of Intraocular Lenses After Cataract Surgery- Hydrophobic Vs. Hydrophilic Lenses - Health Technology Assessment In Slovak Healthcare Environment

    Oct 1, 2017, 00:00

  • Assessing The Implications Of The Nice Budget Impact Test- How Many Oncology Regimens Will Be Affected And What Will Be The Impact On Patient Outcomes?

    Oct 1, 2017, 00:00

  • The Use Of Intra-Class Correlation Coefficients To Assess Test-Retest Reliabilities In Psychometric Evaluations Of Patient Reported Outcome Measures

    Oct 1, 2017, 00:00

  • Budgetary Impact Analysis of the Nutritional Home Care Service

    Oct 1, 2017, 00:00

  • Nice’s New Budget Impact Threshold – What Proportion Of Drugs Is This Likely To Affect?

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Insulin Degludec Versus Insulin Glargine U100 In Type 1 And Type 2 Diabetes Patients From The Portuguese National Healthcare System Perspective- Evidence From The Switch 12 Trials

    Oct 1, 2017, 00:00

  • Constituição De Protocolos Clínicos E Diretrizes Terapêuticas Para Doenças Negligenciadas No Brasil

    Oct 1, 2017, 00:00

  • A Multicenter, Observational Study To Evaluate Comorbidities In Patients Above 50 Years Of Age – Aging Positive- Characterization Of The Healthcare Resource Use

    Oct 1, 2017, 00:00

  • Economic Evaluation of Multi-Drug Resistant Tuberculosis In Ghana- Patient Level Direct Cost Analysis 2013 - 2016

    Oct 1, 2017, 00:00

  • Treatment Patterns Of Second-Line (2L) Metastatic Urothelial Cancer (MUC) In Spain

    Oct 1, 2017, 00:00

  • Interrogating Social Media Sources to Gain Insight on Opioid-Induced Constipation Symptoms as Reported By Patients

    Oct 1, 2017, 00:00

  • Cataract Prevalence Estimation and Financial Requirements for Surgery Unmet Needs in Mexico- A Secondary Sources Analysis

    Oct 1, 2017, 00:00

  • Estimating The Excess Costs of Community-Acquired Pneumonia In Elderly People In Japan

    Oct 1, 2017, 00:00

  • Incorporating Dependence Between Model Parameters In Uncertainty Analyses

    Oct 1, 2017, 00:00

  • Impacto Del Índice De Masa Corporal En La Salud Autopercibida- Resultados De La Encuesta Nacional De Salud De Chile 2016-2017

    Oct 1, 2017, 00:00

  • A Saúde Do Trabalhador Em Questão- Análise Do Absenteísmo E O Perfil Dos Atestados Médicos Em Um Hospital De Grande Porte No Ceará

    Oct 1, 2017, 00:00

  • Detection And Management Of Diabetes In England- Results From The Health Survey For England

    Oct 1, 2017, 00:00

  • Impact of Disease Activity Measures on Health Utilities in PPMS

    Oct 1, 2017, 00:00

  • The Value Of Real-World Evidence To Support Value-Based Decision-Making- Examples For Vedolizumab In Inflammatory Bowel Disease

    Oct 1, 2017, 00:00

  • Cost Effectiveness of Universal Neonatal Hearing Screening With Otoacoustic Emissions And/Or Automated Auditory Brainstem Response, For The Detection Of Bilateral Congenital Hearing Loss And Early Treatment, In Newborns Without Risk Factors ...

    Oct 1, 2017, 00:00

  • Neutrophil-To-Lymphocyte Ratio (NLR) As A Predictor For Recurrencein Patients With Stage Iii Melanoma

    Oct 1, 2017, 00:00

  • Primary Treatment Patterns Among Glaucoma Patients In Korea From 2002 To 2013 Using The National Health Insurance System Claims Data

    Oct 1, 2017, 00:00

  • Cost Effectiveness of Ribociclib Plus Letrozole Versus Palbociclib Plus Letrozole for The Treatment of Post-Menopausal Women with Hormone Receptor-Positive (HR+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Advanced or Metasta ...

    Oct 1, 2017, 00:00

  • ADC, NOT AS EASY AS 123 - The Unprecedented Example Of Trastuzumab-Emtansine In The Nice Appraisal Process

    Oct 1, 2017, 00:00

  • Quality of life improvement in a heart failure clinical program vs. Conventional management in a specialized clinic in colombia

    Oct 1, 2017, 00:00

  • Primary Data Collection Versus use of Retrospective Claims Data- Methodology Lessons Learned from A Linked Database Study in Chronic Obstructive Pulmonary Disease (COPD)

    Oct 1, 2017, 00:00

  • Which Are The Most Common Quality of Life Health States In Latin America? A Pareto Analysis of A Collaborative Project Using Euroqol Eq-5d In Argentina, Brazil, Chile and Uruguay

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Analysis of Strategies for Cervical Cancer Prevention and Control in Indonesia

    Oct 1, 2017, 00:00

  • Forecasting Pharmaceutical Expenditure In Europe- Adjusting For The Impact Of Rebates And Discounts

    Oct 1, 2017, 00:00

  • Value of Needleless Safety Devices For IV Voriconazole In Prevention of Needlestick Injury (NSI)

    Oct 1, 2017, 00:00

  • Establishing A Medication Error Reporting And Monitoring Programme In A Developing Country’s Tertiary Care Teaching Hospital

    Oct 1, 2017, 00:00

  • A Literature Review of Health Economic Assessments, Health Care Resource Utilization (HCRU), and Health Related Quality-of-Life (HRQOL) in Patients with Gastric Cancer (GC)

    Oct 1, 2017, 00:00

  • Health Service Implications Of The Implementation Of An Early Discharge Strategy For Patients Admitted In Infectious Diseases Departments In Southern Europe

    Oct 1, 2017, 00:00

  • Discrete Event Simulation Modelling of Long Term Cost-Effectiveness of Internet-Based Blended Cognitive Behavioural Therapy for Major Depressive Disorder- Extrapolation of the E-Compared Randomised Controlled Trial

    Oct 1, 2017, 00:00

  • Estimation of The Health Benefit Associated With A Potential Denosumab-Induced Extension of Progression Free Survival In Multiple Myeloma Patients

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of 10% Intravenous Immunoglobulin Compared With Plasma Exchange In Treatment Of Children With Guillain–Barré Syndrome In Russia

    Oct 1, 2017, 00:00

  • Evaluation of Barriers To Effective Insulin Therapy Among Type 2 Diabetes Mellitus Patients

    Oct 1, 2017, 00:00

  • Prevalence of Overweight and Obesity Among Health Personnel in an Urban Ghana- A Descriptive Cross-Sectional Study, 2017

    Oct 1, 2017, 00:00

  • A Markov Microsimulation Model For The Economic Evaluation Of Partially Implantable Active Middle Ear Implants In Sensorineural Hearing Loss

    Oct 1, 2017, 00:00

  • No Evidence For An Association Between Renal Function And Bleeding Events In Patients On Coumarin Therapy- A Population-Based Study

    Oct 1, 2017, 00:00

  • The Economic Burden of Coeliac Disease in North America and Europe- A Systematic Review

    Oct 1, 2017, 00:00

  • Are LABA/LAMA/ICS FDCS A Triple Threat for COPD Competitors in the Cost-Constrained EU5?

    Oct 1, 2017, 00:00

  • Spirometry Comparison Between Smokers and Non-Smokers Students in University of Balochistan,Quetta, Pakistan

    Oct 1, 2017, 00:00

  • Exploring Concurrent Validity of The CLN2 Clinical Rating Scale- Comparison To Pedsql Using Mixed Effects Modelling And Data From A Phase 1/2 Single-Arm Trial

    Oct 1, 2017, 00:00

  • Determining The Brazilian Population Health Status- Estimate Of Health Production Function

    Oct 1, 2017, 00:00

  • ASSOCIATION Between Second-Line Therapy (2LT) Regimen Type, Duration of Therapy (DOT), and Time To Next Treatment (TTNT) In A United States (US) Relapsed/Refractory Multiple Myeloma (RRMM) Cohort- An Electronic Medical Records (EMR)-Based S ...

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Evaluation Of Phid-CV Versus PCV-13 In Slovakia

    Oct 1, 2017, 00:00

  • Subcutaneous Drugs In Oncology- Make A Difference In The Treatment? Systematic Review From Different Analytical Perspectives

    Oct 1, 2017, 00:00

  • Symptoms and Impacts in Metastatic Castration-Resistant Prostate Cancer- Qualitative Study Findings

    Oct 1, 2017, 00:00

  • Approaches To Modelling The Cost-Effectiveness Of Interventions For Heart Failure- A Systematic Review

    Oct 1, 2017, 00:00

  • Coverage Evidence Development in the Course of the Drug Reevaluation in Korea

    Oct 1, 2017, 00:00

  • Quality-Adjusted Life Years (QALYS) for Inotuzumab Ozogamicin Versus Investigators Choice (IC) for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukaemia (R/R B-ALL)

    Oct 1, 2017, 00:00

  • Custos Diretos No Tratamento De Câncer De Mama- Olhar Estratégico De Uma Operadora De Planos De Saúde Do Brasil

    Oct 1, 2017, 00:00

  • The Comparison Among Different Countries’ EQ-5D-5L Value Sets Applied In Chinese General Population

    Oct 1, 2017, 00:00

  • Low Density Lipoprotein Cholesterol (LDL-C) Target Goal Achievement Rate According to Physicians’ Compliance to Established Clinical Guidelines from National Cholesterol Education Program-Adult Treatment Panel (NCEP-ATP) and American Colleg ...

    Oct 1, 2017, 00:00

  • Brazilian Public Healthcare System Actions to Care For Children With Microcephaly

    Oct 1, 2017, 00:00

  • Drug Commercialization Before The Pricing And Reimbursement In Italy- The Non Negotiated C Class (C-NN)

    Oct 1, 2017, 00:00

  • Comparative Analysis of Lists of Antifungal Preparations for Onychomycosis Treatment In British and Ukrainian National Formularies

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of The Sufentanil Sublingual Tablet System Vs Iv Pca Morphine For The Treatment of Acute Moderate To Severe Post-Operative Pain In Ireland

    Oct 1, 2017, 00:00

  • Evaluating The Cost-Utility Of Immunosuppressive Regimens In Liver Transplant Recipients In Canada

    Oct 1, 2017, 00:00

  • A Via Administrativa E Judicial Como Forma De Acesso Aos Medicamentos No Sistema Público De Saúde Brasileiro

    Oct 1, 2017, 00:00

  • The Cost and Outcomes of Breast Cancer Screening for Women 40-49 Years Old in Russia

    Oct 1, 2017, 00:00

  • Quality of Life of Pregnant Women in Russian Federation

    Oct 1, 2017, 00:00

  • Advanced Therapy Medicinal Products – Transformational Patient Benefits But Destined for Commercial Failure?

    Oct 1, 2017, 00:00

  • Target Organ Damage And The Long Term Effect of Nonadherence To Clinical Practice Guidelines In Patients With Hypertension- A Retrospective Cohort Study

    Oct 1, 2017, 00:00

  • Cost-Utility Analysis of A Novel Breath-Triggered Aerosol Inhaler Which Has Been Designed To Reduce The Critical Handling Error of Insufficient Inspiratory Effort

    Oct 1, 2017, 00:00

  • Inconclusive Eviden Can Pharmacoeconomics Tilt The Balance?

    Oct 1, 2017, 00:00

  • Burn Care Outside Burn Centers In Germany; Results From An Analysis of Hospital Quality Reports

    Oct 1, 2017, 00:00

  • Is it Possible to Accurately Identify Rare Diseases Using National Hospital Discharge Databases?

    Oct 1, 2017, 00:00

  • Non-Quantifiable Benefit Within The German Amnog System- Factors Contributing To Time Limits Set For Benefit Resolutions And Potential Implications On Price Discounts

    Oct 1, 2017, 00:00

  • Antecipação Ao Rol De Procedimentos Da Agência Nacional De Saúde Suplementar- Impacto Orçamentário Da Incorporação De Um Novo Inibidor De Tirosina-Quinase

    Oct 1, 2017, 00:00

  • Association Between Tumour Lesion Size and Health-Related Quality of Life Outcomes in Patients with Metastatic Merkel Cell Carcinoma Treated with Avelumab

    Oct 1, 2017, 00:00

  • MÉTODOS DE ANÁLISE MULTICRITÉRIO EMPREGADOS NA SELEÇÃO DE MEDICAMENTOS

    Oct 1, 2017, 00:00

  • The Value Of Beds With Continuous Lateral Rotation Therapy To Prevent Ventilator-Associated Pneumonia And Pressure Injuries- A Cost-Effectiveness Analysis

    Oct 1, 2017, 00:00

  • Cost Saving Analysis of Encephalogram Bispectral Index Monitoring (Bis) During Ten Different Types of Elective Surgeries in Colombia

    Oct 1, 2017, 00:00

  • Intravenous Iron Treatments For Iron Deficiency Anemia In Inflammatory Bowel Disease- A Budget Impact Analysis Of Iron Isomaltoside 1000 In The UK

    Oct 1, 2017, 00:00

  • Budget Impact Analysis For Switching From Manual To Pre-Filled Syringes For Catheter Maintenance

    Oct 1, 2017, 00:00

  • Electronic Patient-Reported Outcomes- Are There Gaps Between Guidance And Issues Encountered In Practice?

    Oct 1, 2017, 00:00

  • Newly Diagnosed Multiple Myeloma (NDMM) Patient Profiles; Findings From An Observational Chart Review In France, Germany, Italy, Spain And The United Kingdom

    Oct 1, 2017, 00:00

  • Cognitive Debriefing Of The Dmd-Specific Measures Of Physical Functioning – Caregiver Questionnaire

    Oct 1, 2017, 00:00

  • Preliminary Results Of Benefits Study - Brazilian Economic Evaluation Of Sflt-1/Plgf Test For Preeclampsia Prediction And Diagnosis- Private Perspective

    Oct 1, 2017, 00:00

  • Calculating The Indirect Costs Of Adult Pneumococcal Disease And The Rate Of Return To The 13-Valent Pneumococcal Conjugate Vaccine (PCV13) In Older Adults, With An Application To Denmark

    Oct 1, 2017, 00:00

  • A Review Of Economic Evaluations Considering Screening Interventions For The Risk Assessment Of Venous Thromboembolism In Women Considering Combined Oral Contraceptives

    Oct 1, 2017, 00:00

  • Uncertainty In Selecting Survival Models For Cost Effectiveness Analyses

    Oct 1, 2017, 00:00

  • Pro-Ctcae Impact on Payer Evaluations of Oncologic Therapies- A Qualitative Research Study

    Oct 1, 2017, 00:00

  • A Cost Consequences Analysis of The Human Body Posturizer In Italy

    Oct 1, 2017, 00:00

  • Cost-Utility Of Prasugrel Compared To Clopidogrel For Preventing Cardiovascular Events In Diabetic Patients With Acute Coronary Syndrome In Brazil

    Oct 1, 2017, 00:00

  • A Multi-Centre Retrospective Study To Describe The Impact on Healthcare Resource Use And Real World Effectiveness of Golimumab In Ankylosing Spondylitis (AS) In UK Clinical Practice

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Daclizumab Beta In The Treatment of Relapsing Remitting Multiple Sclerosis In Italy

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Invasive Fungal Infections Therapies In Febrile Neutropenic Patients With Hematological Malignancies In The Turkish Context

    Oct 1, 2017, 00:00

  • Diagnosis Of Patients With Duchenne Muscular Dystrophy (DMD)- Results From A Global Survey Of Healthcare Providers From Nine Countries

    Oct 1, 2017, 00:00

  • Biosimilar Uptake In The Uk- An Evolving Story?

    Oct 1, 2017, 00:00

  • Multiple Chronic Conditions in Older People and their Effects on Health Care Utilization- A Network Analysis Approach Using Share Data

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of A Direct Aspiration First Pass Technique (ADAPT) For Thrombectomy Revascularization of Large Vessel Occlusion In Acute Ischemic Stroke (French Health Ministry Prme 16-0020)

    Oct 1, 2017, 00:00

  • An Empirical Analysis of The Role of Learning by Doing in Dynamic Cost-Effectiveness

    Oct 1, 2017, 00:00

  • Availability of Health Economic Model Inputs In Japan- A Targeted Literature Review

    Oct 1, 2017, 00:00

  • Results Of Individual Participant Data Meta-Analysis VS Aggregate Data Meta-Analysis Of RCTS Of Exercise Rehabilitation In Chronic Heart Failure

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Prasugrel For Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention In Spain

    Oct 1, 2017, 00:00

  • When The Outcome of An Appraisal Is Not Ni A Review Of Nice Appeals

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Coblation Technology VS. Mechanical Debridement With A Shaver In The Treatment Of Knee Cartilage Lesions- A Spanish Payer Perspective

    Oct 1, 2017, 00:00

  • Cost Of Hospitalizations For Nontuberculous Mycobacterial Pulmonary Disease In France In 2014- A PMSI Database Analysis

    Oct 1, 2017, 00:00

  • Patient Counts Based on The Most Commonly Funded Diseases In Home Special Care In Hungary, 2013

    Oct 1, 2017, 00:00

  • Characterising the Relative Impact of Established Cardiovascular Disease and Chronic Kidney Disease on Quality of Life in Diabetes Patients

    Oct 1, 2017, 00:00

  • Identifying Patients With Lupus Nephritis in the United Kingdom (Uk) Clinical Practice Research Datalink (Cprd)

    Oct 1, 2017, 00:00

  • Comparative Efficacy And Safety Of Olaparib 300 Mg Tablets Bid And Niraparib 300 Mg Tablets QD As Maintenance Treatment After Response To Chemotherapy In Patients With Platinum-Sensitive Relapsed Germline BRCA-Mutated Ovarian Cancer (PSROC) ...

    Oct 1, 2017, 00:00

  • Lipid-Lowering Treatment Patterns and Possible Associated Statin Intolerance in Patients with Clinical Atherosclerotic Cardiovascular Disease (ASCVD) or Diabetes Mellitus (DM) in Taiwan

    Oct 1, 2017, 00:00

  • Use of Abiraterone And Enzalutamide In Metastatic Castration-Resistant Prostate Cancer In Routine Clinical Practice

    Oct 1, 2017, 00:00

  • Metodology To Assess Pricing And Reimburesment (PR) Potential In Central And European (CEE) Countries

    Oct 1, 2017, 00:00

  • Number Needed to Treat (NNT) and Cost of Preventing an Event (COPE) Comparison Between the Association of Cobimetinib and Vemurafenib Among Other Treatment Options for Metastatic Melanoma With BRAF V600 Mutation

    Oct 1, 2017, 00:00

  • Análise Da Qualidade Da Evidência Científica Entre Xelox E Folfox No Tratamento Do Câncer Colorretal

    Oct 1, 2017, 00:00

  • How To Address French Health Authority (HAS/CEESP) Specific Requirements In Modelling Relapsing-Remitting Multiple Sclerosis In Health-Economic Evaluation? Modelling Treatment Sequences

    Oct 1, 2017, 00:00

  • Treatment Persistence In Psoriasis Patients Initiated on Apremilast, Oral Systemics, or Biologic Therapies

    Oct 1, 2017, 00:00

  • Uso De Medicamentos Inapropriados Em Idosos Institucionalizados No Município De São Paulo, Brasil

    Oct 1, 2017, 00:00

  • Pre-Hospital Pain Relief Treatment In Patients With Musculoskeletal Injuries Experiencing Moderate To Severe Pain In Medical Emergencies

    Oct 1, 2017, 00:00

  • Prospective Assessment of The Accuracy, Reliability and Cost-Effectiveness of Staging Non-Small Cell Lung Cancer (NSCLC) Only with The Combination of Pet/Ct and Brain MRI

    Oct 1, 2017, 00:00

  • The Impact of Missed Treatment Opportunities on Outcomes In Hospitalised Heart Failure Patients- Modelling Analysis Based on The National Heart Failure Audit

    Oct 1, 2017, 00:00

  • Pharmacy Workload And Workforce Requirement At Ministry Of Health Hospitals During Ten Years Mass Gathering Hajj (2006-2015) In Makah Region, Saudi Arabia

    Oct 1, 2017, 00:00

  • Acceptance of Population-Adjusted Indirect Treatment Comparison Methods In Nice Assessments

    Oct 1, 2017, 00:00

  • Reliability, Validity and Responsiveness of A New Measure of Neck Disability (ND10)

    Oct 1, 2017, 00:00

  • Pricing Pantoprazole In Gree A Tale Of Distortion

    Oct 1, 2017, 00:00

  • The Effect of Changing Utility Elicitation Methods in Cardiovascular Disease- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Reliability And Validity Of The Mobility Section Of The Prosthesis Evaluation Questionnaire And Its Modified Version. Do They Measure The Same Construct?

    Oct 1, 2017, 00:00

  • Preferences of Parents To Avoid Oral Health Outcomes In Children- Results of A Discrete Choice Experiment

    Oct 1, 2017, 00:00

  • Surgical Treatment Outcome of Lumbar Disc Herniation (LDH) In Different Ages

    Oct 1, 2017, 00:00

  • Patient Preferences for Interferon-Beta in Iran- A Discrete Choice Experiment

    Oct 1, 2017, 00:00

  • Clinical Characteristics Of Patients With Chronic Hepatitis C Infection At Initial Presentation To Tertiary Care In An Asian Middle-Income Country

    Oct 1, 2017, 00:00

  • Cost of Acute Myocardial Infarction in Colombia (2014)

    Oct 1, 2017, 00:00

  • Can Bayesian Methodology Predict Long-Term Effectiveness Rather Than Efficacy? An Application with Overall Survival in Two Oncology Indications

    Oct 1, 2017, 00:00

  • Healthcare Resource Utilization And Cost Of Patients With Acute Coronary Syndromes In Tianjin, China

    Oct 1, 2017, 00:00

  • Assessing the Burden of Chronic Heart Failure on Caregivers of Patients in Colombia

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Evaluation of a Care Bundle Intervention for Preventing Falls Among Italian Aged Inpatients in a Stepped-Wedge Cluster Randomized Controlled Trial

    Oct 1, 2017, 00:00

  • Parametric Modelling of Migraine Day Frequency In Migraine Prevention- A Case Study Of Erenumab Clinical Trial Data

    Oct 1, 2017, 00:00

  • Medicine Prices Disparity Among Retail Pharmacies In Selangor, Malaysia

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Midostaurin (MIDO) with Standard Chemotherapy (SOC) for Acute Myeloid Leukemia (AML) in the United Kingdom (UK)

    Oct 1, 2017, 00:00

  • Attitudes Towards Generic Substitution In Greece

    Oct 1, 2017, 00:00

  • Angiotensin II Receptor Blockers And Intestinal Malabsorption- An Observational Cohort Study In Germany And Italy

    Oct 1, 2017, 00:00

  • Internet Based Treatment of Depressive Symptoms – A Health Economic Evaluation of Costs and Benefits

    Oct 1, 2017, 00:00

  • Pharmatool- An Economic and Epidemiological Calculation Tool To Aid Planning For Reducing Cardiovascular Morbidity In Brazil

    Oct 1, 2017, 00:00

  • Patients Oriented Access Scheme- Learning From The Success Of The Israeli Innovative Solution For The Escalating Drugs Prices

    Oct 1, 2017, 00:00

  • In What Sequence Do Companies Submit Health Technology Appraisal (HTA) Dossiers In The UK And Ireland, And In What Sequence Are They Published?

    Oct 1, 2017, 00:00

  • Comparison of Budesonide Inhalers For Treatment of Asthma In Adults And Adolescents In Russian Federation- Cost – Effectiveness Analysis

    Oct 1, 2017, 00:00

  • The Economic Impact of Switching To Herceptin (TRASTUZUMAB) Biosimilar for The Treatment of Metastatic Breast Cancer From A UK Payer Perspective

    Oct 1, 2017, 00:00

  • Analysis of The Budget Impact of Secukinumab use Versus Anti-Tnf Agents in Ankylosing Spondylitis Patients

    Oct 1, 2017, 00:00

  • Clinical and Patient Reported Outcomes In Psoriatic Arthritis- A Narrative Review of The Literature

    Oct 1, 2017, 00:00

  • New Modelling Approaches In Ophthalmology- Partitioned Vision Distrbution Model In Symptomatic Vitreomacular Adhesion (VMA)/Vitreomacular Traction (VMT) With Or Without Full-Thickness Macular Hole (FTMH)

    Oct 1, 2017, 00:00

  • The Potential Value Of Real-World Evidence Along With Trial Efficacy To Estimate Effectiveness Of Novel Treatments In Real-World Setting; An Application With Overall Survival In Two Oncology Indications

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Quadrivalent Influenza Vaccine For National Immunization Program In South Korea

    Oct 1, 2017, 00:00

  • Measurement Of Multimorbidity To Predict All-Cause Mortality In A Nationwide Population, Using The French National Health Insurance Database (SNIIRAM)

    Oct 1, 2017, 00:00

  • Burden Of Respiratory Syncytial Virus (RSV) Disease In Adults- Final Analysis From A Retrospective Chart Review

    Oct 1, 2017, 00:00

  • Off-Label Drug Use In Hospitalized Children- A Prospective Observational Study At Gondar University Referral Hospital, Northwestern Ethiopia

    Oct 1, 2017, 00:00

  • Costo-Efectividad De La Cirugía Bariátrica En Colombia

    Oct 1, 2017, 00:00

  • Barriers To Access And Pricing Negotiations Criterial Selection For Novel Treatments For Hepatitis C In The Greek Healthcare Context

    Oct 1, 2017, 00:00

  • Efficacy and Safety of Interferon-Free Therapies For Chronic Hepatitis C Patients Coinfected With Hiv- Systematic Review of Clinical Trials

    Oct 1, 2017, 00:00

  • Impact Of Genomic Testing Billing Practices On Utilization In Academic Hybrid Oncology Practice

    Oct 1, 2017, 00:00

  • Great Saphenous Vein Radiofrequency Ablation Versus Standard Stripping in The Management of Primary Varicose Veins- Economic Evaluation Into the Mexican Context

    Oct 1, 2017, 00:00

  • Cost and Treatment of Asthma and Copd in the Real Practi A Regional Segmentation

    Oct 1, 2017, 00:00

  • Counterfactual Decomposition Of Health Care Expenditures- From Cost-Based Payment To Global Budget System

    Oct 1, 2017, 00:00

  • The Cost Of Treating Diabetic Ketoacidosis In The UK- A National Survey Of Hospital Resource Use

    Oct 1, 2017, 00:00

  • Health State Utilities Associated with Treatment Options for Acute Myeloid Leukemia (AML)

    Oct 1, 2017, 00:00

  • Modeling Covariate-Adjusted Survival for Economic Evaluations in Oncology

    Oct 1, 2017, 00:00

  • Recruiting Metastatic Patients into Non-Small Cell Lung Cancer Studies (NSCLC)- Lessons Learned from A Non-Interventional Study of NSCLC Patients with Central Nervous System (CNS) Metastases (METS) and Non-CNS Mets

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Easypod™ Device Versus Other Somatotropin Delivery Techniques In Egypt In Treatment of Growth Hormone Deficiency

    Oct 1, 2017, 00:00

  • Health Care Use Among Incident Cases of Heart Failure- A Population-Based Cohort Study from 1997 To 2010

    Oct 1, 2017, 00:00

  • Treatment Cost of Hepatocellular Carcinoma from The Health Insurance’s Perspective in Viet Nam

    Oct 1, 2017, 00:00

  • Public Health And Economic Benefits Of Quadrivalent Influenza Vaccine In Mexico

    Oct 1, 2017, 00:00

  • Evaluation of Appropriateness of Antibiotics in the Intensive Care Unit of a Tertiary Care Hospital

    Oct 1, 2017, 00:00

  • A Budget Impact Analysis Of Increasing Peritoneal Dialysis (PD) In Adults Experiencing Unplanned Start Dialisys (Urgent Start) In Brazil

    Oct 1, 2017, 00:00

  • Treatment Sequencing for Patients With Multiple Myeloma with at Least One Prior Line- Comparing Progression-Free Survival and Costs Under a Private Payer Perspective

    Oct 1, 2017, 00:00

  • Experiences With Price Competition Of Biosimilar Drugs In Hungary

    Oct 1, 2017, 00:00

  • Evaluation of The Long-Term Cost-Effectiveness Of Real Time Continuous Glucose Monitoring (RTCGM) Versus Self Monitoring Of Blood Glucose (SMBG) Alone In Type 1 Diabetes From The Swedish Societal Perspective

    Oct 1, 2017, 00:00

  • Determinantes Dos Custos Dos Processos Judiciais De Medicamentos Em Um Município Da Região Centro-Oeste Do Brasil

    Oct 1, 2017, 00:00

  • Review Of Reimbursement Decision Drivers For Rare Cancer Therapies Across EU5 Markets

    Oct 1, 2017, 00:00

  • Evaltuation of The National Drug Formularium and Electronic Catalog For The Indonesian UHC

    Oct 1, 2017, 00:00

  • Health-Related Quality-Of-Life And Utility Measures Impact In A Randomized Controlled Study Of Fine Needle Aspiration Cytology (FNAC) Versus Watchful Observation In Patients With Incidental Symptomatic Thyroid Nodules

    Oct 1, 2017, 00:00

  • Evaluating Matching-Adjusted Indirect Comparison and Simulated Treatment Comparison Techniques- Impact on Health-Related Quality of Life of Focussed Ultrasound Thalamotomy and Other Interventions for the Treatment of Medication-Refractory E ...

    Oct 1, 2017, 00:00

  • The Associated Factors of Neuropathic Pain Among Chronic Low Back Pain Patients in South Korea- Findings from the NLBP OR

    Oct 1, 2017, 00:00

  • Using Observational Data From Registry In Cost-Effectiveness Evaluation of Metastatic Castration Resistant Prostate Cancer In France

    Oct 1, 2017, 00:00

  • The Economic Impact of Rheumatoid Arthritis on Patients’ Households. An Estimation of The Disease Related Catastrophic Health Expenditure, In Greece

    Oct 1, 2017, 00:00

  • Systematic Review of The Cost-Effectiveness of Medicines For The Treatment of Idiopathic Pulmonary Fibrosis

    Oct 1, 2017, 00:00

  • Identifying the Challenges to Adult Influenza Vaccination in Latin America

    Oct 1, 2017, 00:00
  • «
  • 71
  • 72
  • 73 (current)
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • »